F10 and peripheral arterial disease: A genome-wide association study suggests that there are genetic loci common for disease in the coronary, cerebral and peripheral arterial beds, and loci variants specific for PAD involved in pathways promoting thrombosis, providing genetic support for Factor Xa inhibition as a therapeutic strategy for PAD48.